Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate orion 54 mg depottablett
orion corporation - metylfenidathydroklorid - depottablett - 54 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 44,28 mg aktiv substans; metylfenidathydroklorid 9,72 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate orion 18 mg depottablett
orion corporation - metylfenidathydroklorid - depottablett - 18 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 3,24 mg aktiv substans; metylfenidathydroklorid 14,76 mg aktiv substans
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate generis 27 mg depottablett
generis farmacêutica, sa - metylfenidathydroklorid - depottablett - 27 mg - metylfenidathydroklorid 22,14 mg aktiv substans; metylfenidathydroklorid 4,86 mg aktiv substans; laktosmonohydrat hjälpämne
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate generis 18 mg depottablett
generis farmacêutica, sa - metylfenidathydroklorid - depottablett - 18 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 14,76 mg aktiv substans; metylfenidathydroklorid 3,24 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate generis 54 mg depottablett
generis farmacêutica, sa - metylfenidathydroklorid - depottablett - 54 mg - metylfenidathydroklorid 44,28 mg aktiv substans; metylfenidathydroklorid 9,72 mg aktiv substans; laktosmonohydrat hjälpämne